Literature DB >> 27939834

Focus on the role of Caveolin and Cavin protein families in liposarcoma.

Silvia Codenotti1, Marika Vezzoli1, Eugenio Monti1, Alessandro Fanzani2.   

Abstract

The identification of ancillary biomarkers useful to improve diagnosis is a major challenge for adipocytic liposarcoma (LPS), the most common type among soft tissue sarcomas affecting adulthood. Recent findings have reported the expression of some proteins belonging to Caveolin and Cavin families as a critical hallmark distinctive of the least aggressive, well-differentiated LPS tumors. These proteins are involved in the biogenesis, morphology and function of caveolae, minute bulb-shaped domains of the plasma membrane that play a crucial role in the adipose tissue by controlling hormone-dependent uptake of nutrients and contributing to the maintenance of tissue integrity. In light of this, in this paper we covered different topics, including metabolism, hypoxia and cell mechanoprotection, to outline the rationale for considering a deeper investigation of Caveolin and Cavin protein members in LPS neoplasms as an opportunity to identify pro-differentiating mechanisms that could counteract tumor growth.
Copyright © 2016 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipocytes; Caveolae; Caveolins; Cavins; Liposarcoma; Metabolism

Mesh:

Substances:

Year:  2016        PMID: 27939834     DOI: 10.1016/j.diff.2016.11.007

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  2 in total

1.  Pleomorphic Liposarcoma of Femur: A Rare Soft Tissue Sarcoma Metastasized to the Bone-Case Report and Review of Literature.

Authors:  Thanate Poosiripinyo; Thanapon Chobpenthai; Taweechok Wisanuyotin; Winai Sirichativapee
Journal:  Case Rep Orthop       Date:  2022-03-07

Review 2.  Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment.

Authors:  Lingge Yang; Shiqi Chen; Peng Luo; Wangjun Yan; Chunmeng Wang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.